Tumour Activity or Liver Damage

[1]  A. V. van Oosterom,et al.  Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Sleijfer,et al.  Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin‐vinblastine‐bleomycin chemotherapy , 1988, Journal of surgical oncology.

[3]  S. Govindarajan,et al.  Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors. , 1987, American journal of clinical pathology.

[4]  D. Chan,et al.  Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients. , 1986, Clinical chemistry.

[5]  D. Sleijfer,et al.  Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors , 1986, Cancer.

[6]  R. Rowland,et al.  The role of surgery in advanced testicular cancer , 1984, Cancer.

[7]  M. Isemura,et al.  Differential reactivity of α-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma , 1984 .

[8]  P. Buamah,et al.  Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells. , 1984, Clinical chemistry.

[9]  I. Gibb,et al.  Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[10]  D. Skinner,et al.  Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report. , 1984, The Journal of urology.

[11]  H. Bell.  Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease. , 1982, Scandinavian journal of gastroenterology.

[12]  H. Pinedo,et al.  COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA , 1979, The Lancet.

[13]  L. Einhorn,et al.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. , 1977, Annals of internal medicine.

[14]  Ding‐Shinn Chen,et al.  Serum alphafetoprotein in hepatocellular carcinoma , 1977, Cancer.

[15]  T. Waldmann,et al.  Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract , 1975 .

[16]  J. Kohn,et al.  Serum-alpha 1-fetoprotein in hepatocellular carcinoma. , 1974, Lancet.

[17]  Y. Tsuchida,et al.  Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures. , 1989, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[18]  K. Taketa,et al.  Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma. , 1989, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[19]  H. Taga,et al.  Early diagnosis of hepatocellular carcinoma with lectin electrophoresis of serum alpha-fetoprotein. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[20]  J. Bręborowicz.  Microheterogeneity of human alphafetoprotein. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.